<DOC>
	<DOCNO>NCT00167986</DOCNO>
	<brief_summary>To determine whether restriction 3rd generation cephalosporin carbapenems contribute reduction intestinal colonization infection vancomycin-resistant enterococci ( VRE ) medical intensive care unit ( MICU ) .</brief_summary>
	<brief_title>Study Evaluating Antibiotic Use Reducing Vancomycin-Resistant Enterococci ESBL Producing Escherichia Coli Klebsiella Pneumoniae Intensive Care</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Klebsiella Infections</mesh_term>
	<mesh_term>Escherichia coli Infections</mesh_term>
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<mesh_term>Vancomycin</mesh_term>
	<criteria>All patient admit transferred MICU . Patients 18 year age old . Provide write informed consent . Patients know infected colonized VRE ESBLproducing E.coli , K.pneumoniae . Patients hypersensitivity penicillin . Any underlying condition diseases ultimately fatal within 48 hour . Any concurrent condition medication would interfere absorption metabolism study drug .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2007</verification_date>
	<keyword>Bacterial Infections</keyword>
</DOC>